PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Interregional Department No. 1 of the Federal Medical and Biological Agency; FSBSI «I.I. Mechnikov Research Institute of Vaccines and Sera».\', \'FSBI «National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya» of the Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University).\', \'FSBSI «I.I. Mechnikov Research Institute of Vaccines and Sera»; I.M. Sechenov First Moscow State Medical University (Sechenov University).\', \'FSBSI «I.I. Mechnikov Research Institute of Vaccines and Sera».\', \'FSBSI «I.I. Mechnikov Research Institute of Vaccines and Sera»; FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.36233/0507-4088-40
?:hasPublicationType
?:journal
  • Voprosy virusologii
is ?:pmid of
?:pmid
?:pmid
  • 33993685
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.179
?:rankingScore_hIndex
  • 12
is ?:relation_isRelatedTo_publication of
?:title
  • [Reactivation of Epstein-Barr virus (Herpesviridae: Lymphocryptovirus, HHV-4) infection during COVID-19: epidemiological features].
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all